Project List
List projects.
Fields
id (integer)
Primary key.
Expansions
To activate relation expansion add the desired fields as a comma separated
list to the expand query parameter like this:
?expand=<field>,<field>,<field>,...
The following relational fields can be expanded:
organizationcategorytypepartner_functionmanagercontactstatusgrantresearcheventstudylanguageprogramfunders
Filters
To filter for exact value matches:
?<fieldname>=<value>
Possible exact filters:
organizationcategorymanagercontactstatusgrantresearchstudylanguagefundersprogram
For advanced filtering use lookups:
?<fieldname>__<lookup>=<value>
All fields with advanced lookups can also be used for exact value matches as described above.
Possible advanced lookups:
begin_planned:gt,gte,lt,ltebegin_effective:gt,gte,lt,lteend_planned:gt,gte,lt,lteend_effective:gt,gte,lt,lte
GET /v1/research/project/?format=api&offset=200&ordering=-end_planned
{ "count": 2243, "next": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=220&ordering=-end_planned", "previous": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=180&ordering=-end_planned", "results": [ { "id": 9218, "title": { "de": "Rätselhafte Aktivierung der präsynaptischen Glykolyse\r\n", "en": "Enigmatic activation mechanism of presynaptic glycolysis\r\n" }, "short": "Activation_presynaptic glycolysis", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2026-01-01T01:00:00+01:00", "begin_effective": "2026-01-01T01:00:00+01:00", "end_planned": "2028-12-31T01:00:00+01:00", "end_effective": "2027-12-31T01:00:00+01:00", "assignment": "2025-09-22T13:45:36+02:00", "program": 118, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 100845, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "TAI1573525", "ethics_committee": null, "edudract_number": null, "persons": [ "9218-100845-10" ] }, { "id": 8465, "title": { "de": "Ansätze zur Frühdiagnose auf Basis von Flüssigbiopsiemarkern", "en": "Approaches for early diagnosis based on liquid biopsy markers" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-06-01T02:00:00+02:00", "begin_effective": "2024-06-01T02:00:00+02:00", "end_planned": "2028-12-31T01:00:00+01:00", "end_effective": "2028-12-31T01:00:00+01:00", "assignment": "2024-10-30T17:30:19+01:00", "program": 94, "subprogram": null, "organization": 14017, "category": 10, "type": 10, "partner_function": 1, "manager": 66435, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8465-66435-10" ] }, { "id": 8233, "title": { "de": "Die Nr4a1/P53 Achse in der Immun Evasion von Lymphomen", "en": "NR4A1-P53 AXIS IN THE IMMUNE EVASION OF AGGRESSIVE LYMPHOMAS" }, "short": "LYMPHO-CHECK", "url": null, "abstract": { "de": "Aggressive Lymphome gehören zu den häufigsten Arten von Lymphdrüsenkrebs und stellen eine große Herausforderung für die Behandlung dar. Checkpoint-Blockade-Therapien (CBTs) haben sich als vielversprechender Weg erwiesen, um der Umgehung der Anti-Tumor-Immunantwort durch den Tumor entgegenzuwirken. Trotz ihres Potenzials sind CBTs mit erheblichen Kosten verbunden und basieren häufig auf Trial-and-Error-Ansätzen. Zudem sprechen nur ein kleiner Prozentsatz der Lymphom-Patienten (10-20%) auf CBT an, teilweise aufgrund eines Mangels an Verständnis darüber, wie Immun-Checkpoints während der Entwicklung von Lymphomen reguliert werden, sowie aufgrund des Fehlens prädiktiver Biomarker. Unsere jüngsten Forschungsergebnisse haben wichtige Faktoren aufgedeckt, die zu schlechten Ergebnissen bei Patienten mit diffusen großzelligen B-Zell-Lymphomen (DLBCL) beitragen. Wir beobachteten signifikante Abnahmen der NR4A1- und p53-Spiegel, die wichtige Regulatoren der Genexpression sind, vergesellschaftet mit erhöhten Checkpoint-Komponenten-Gehalt. Bei Mäusen führte die Deletion von NR4A1 zu reduzierten p53-Spiegeln, beschleunigter Lymphomentwicklung und erhöhter Expression von immuninhibitorischen Checkpoint-Komponenten. Diese Ergebnisse deuten auf eine funktionelle Beziehung zwischen NR4A1 und p53, die in der Immunantwort auf Tumore die Expression von Checkpoint-Komponenten in aggressiven Lymphomen reguliert.\r\nUnser vorgeschlagenes Forschungsprojekt zielt darauf ab, diese Herausforderungen durch die Entwicklung neuer Mausmodelle mit spezifischen Deletionen von NR4A1 und/oder p53 in B-Zellen anzugehen. Unter Verwendung fortschrittlicher molekularer und genomweiter Techniken werden wir umfassend untersuchen, wie Lymphome in diesen Modellen entstehen. Außerdem werden wir eine Methode zur wiederholten Gewebsflüssigkeitsentnahme adaptieren und damit wiederholte Messungen von Zytokinsignalen und zellulären Veränderungen in sich entwickelnden Tumoren durchführen, wodurch wertvolle Einblicke in das Lymphom-Mikromilieu gewonnen werden. Mit Hilfe dieser Modelle hoffen wir, neue Checkpoint-Blockade-Therapien für aggressive Lymphom entwickeln und auf den Status von NR4A1 und p53 abstimmen zu können. Zur Validierung unserer Ergebnisse werden wir eine große Kohorte von Lymphomproben von Patienten analysieren und mit öffentlich verfügbaren Datensätzen vergleichen. Letztendlich ist es unser Ziel, die klinische Relevanz der NR4A1-p53-Checkpoint-Achse zu bewerten und neue Biomarker zu identifizieren, die bei aggressiven Lymphomen als Entscheidungshilfe für die Behandlung mit Checkpoint-Inhibitoren dienen können. Durch unsere Forschung wollen wir die Ergebnisse für Patienten mit aggressiven Lymphomen verbessern, indem wir wirksamere und personalisierte Behandlungsstrategien entwickeln.\r\n", "en": "Aggressive lymphomas are among the most common types of lymphoid cancers and consist of Burkitt’s lymphoma, diffuse large B cell lymphoma (DLBCL), follicular lymphoma grade 3. While checkpoint blockade therapies (CBTs) have emerged as a promising avenue to counteract tumor evasion, this treatment form comes with substantial cost burdens and often rely on trial-and-error approaches. Importantly, only a small percentage of lymphoma patients (10-20%) respond favorably to CBT, partly due to the limited understanding of the regulation of immune checkpoints during lymphoma development and the absence of predictive biomarkers. Our recent investigations have shed light on key factors contributing to poor outcomes in patients with DLBCL. We observed significant decreases in the levels of NR4A1 and p53, which are important regulators of gene expression and known tumor suppressors, alongside high expression of checkpoint components. In mice, depletion of NR4A1 led to reduced p53 levels, accelerated lymphoma development, and increased expression of immune-inhibitory checkpoint components, particularly in animals with intact immune systems. These and other findings suggest a functional relationship involving NR4A1, p53, and the orchestrating immune evasive mechanisms in aggressive lymphomas.\r\nOur proposed research project aims to address this axis by developing new mouse models with specific and inducible deletion of NR4A1 and/or p53 in B cells. Using advanced molecular and genomic techniques, we will comprehensively study lymphoma development in these models. We will also implement a tissue fluid sampling method to repeatedly measure cytokine signals and cellular changes within evolving tumors, providing valuable insights into the lymphoma microenvironment. By leveraging these models, we aim to tailor CBTs based on the status of NR4A1 and p53. To clinically validate our findings, we will analyze a large cohort of lymphoma samples from GRAZ lymphoma cohort and compare them with publicly available datasets. Ultimately, our goal is to functionally establish the clinical relevance of the NR4A1-p53-checkpoint axis and identify new biomarkers that can help guide treatment decisions involving checkpoint inhibitors for aggressive lymphomas. Through our research, we are poised to improve outcomes for patients with aggressive lymphomas by developing more effective and personalized treatment strategies.\r\n" }, "begin_planned": "2024-01-01T01:00:00+01:00", "begin_effective": "2024-06-03T02:00:00+02:00", "end_planned": "2028-12-31T01:00:00+01:00", "end_effective": "2029-06-02T02:00:00+02:00", "assignment": "2024-06-03T13:00:14+02:00", "program": 113, "subprogram": null, "organization": 14082, "category": 10, "type": 10, "partner_function": 3, "manager": 59183, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "FG 30", "ethics_committee": null, "edudract_number": null, "persons": [ "8233-100134-12", "8233-59183-10", "8233-79614-12", "8233-82501-12", "8233-85928-12", "8233-111069-12", "8233-102513-12", "8233-132158-12", "8233-122350-12" ] }, { "id": 9510, "title": { "de": "Gemeinsamer Ansatz: Pflegeherausforderungen durch evidenzbasierte Pflegepraxis und klinische Entscheidungsunterstützung reduzieren", "en": "Collaborative Approach: Reducing Care Challenges Through Evidence-based Nursing Practice and Clinical Decision Support" }, "short": "CARE-CDS", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2026-01-01T01:00:00+01:00", "begin_effective": "2026-04-01T02:00:00+02:00", "end_planned": "2028-12-31T01:00:00+01:00", "end_effective": "2029-03-31T02:00:00+02:00", "assignment": "2025-12-18T13:27:03+01:00", "program": 257, "subprogram": null, "organization": 14080, "category": 10, "type": 10, "partner_function": 3, "manager": 65558, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 416 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "9510-65558-10" ] }, { "id": 8060, "title": { "de": "Modelling Reproductive Failure with Endometrium-On-A-Chip, acib Projekt ID 98.311", "en": "Modelling Reproductive Failure with Endometrium-On-A-Chip, acib Projekt ID 98.311" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-01-01T01:00:00+01:00", "begin_effective": "2024-01-01T01:00:00+01:00", "end_planned": "2028-12-31T01:00:00+01:00", "end_effective": "2028-12-31T01:00:00+01:00", "assignment": "2024-03-01T10:42:56+01:00", "program": 94, "subprogram": null, "organization": 14064, "category": 10, "type": 10, "partner_function": 2, "manager": 75380, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8060-75380-10" ] }, { "id": 8039, "title": { "de": "Modelling Reproductive Failure with Endometrium-On-A-Chip, acib Projekt ID 98.311 ", "en": "Modelling Reproductive Failure with Endometrium-On-A-Chip, acib Projekt ID 98.311 " }, "short": "Endometrium-On-A-Chip", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-01-01T01:00:00+01:00", "begin_effective": "2024-01-01T01:00:00+01:00", "end_planned": "2028-12-31T01:00:00+01:00", "end_effective": "2028-12-31T01:00:00+01:00", "assignment": "2024-02-12T12:22:36+01:00", "program": 94, "subprogram": null, "organization": 14017, "category": 10, "type": 10, "partner_function": 3, "manager": 94195, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8039-94195-10" ] }, { "id": 8764, "title": { "de": "CRP-Sensormessung im Urin mittels smarter Textilien", "en": "Smart textile sensor for analyzing C-reactive protein in urine" }, "short": "UriSens", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2025-01-01T01:00:00+01:00", "begin_effective": "2025-05-01T02:00:00+02:00", "end_planned": "2028-12-31T01:00:00+01:00", "end_effective": "2028-04-30T02:00:00+02:00", "assignment": "2025-04-10T12:52:29+02:00", "program": null, "subprogram": "Schlüsseltechnologien im produktionsnahen Umfeld, 2024", "organization": 14080, "category": 10, "type": 10, "partner_function": 2, "manager": 51809, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 416 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8764-51809-10" ] }, { "id": 8534, "title": { "de": "K Kanal Regler bei IPF\r\n", "en": "K channel regulator in IPF\r\n" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2025-01-01T01:00:00+01:00", "begin_effective": "2025-01-01T01:00:00+01:00", "end_planned": "2028-12-31T01:00:00+01:00", "end_effective": "2028-12-31T01:00:00+01:00", "assignment": "2024-11-28T16:37:05+01:00", "program": 72, "subprogram": null, "organization": 14087, "category": 10, "type": 10, "partner_function": 4, "manager": 58984, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "PAT7985824", "ethics_committee": null, "edudract_number": null, "persons": [ "8534-58984-10" ] }, { "id": 9539, "title": { "de": "Patientenbasiertes Immunprofiling und funktionelle Validierung von Matrikin Effekten in akuter Lungenentzündung/ARDS", "en": "Patient-based immunoprofiling and functional validation of matrikin effects in acute pneumonia/ARDS" }, "short": "Matrix-Immune Axis in ARDS ", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2026-01-01T01:00:00+01:00", "begin_effective": "2026-01-01T01:00:00+01:00", "end_planned": "2028-12-31T01:00:00+01:00", "end_effective": "2026-12-31T01:00:00+01:00", "assignment": "2026-01-21T10:06:24+01:00", "program": null, "subprogram": null, "organization": 14022, "category": 10, "type": 10, "partner_function": 4, "manager": 82595, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2471 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "9539-82595-10" ] }, { "id": 9390, "title": { "de": "Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP 1 - Transversal activities", "en": "Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP 1 - Transversal activities" }, "short": "RESILIENCE-R-2024", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2025-12-01T01:00:00+01:00", "begin_effective": "2025-11-01T01:00:00+01:00", "end_planned": "2028-11-30T01:00:00+01:00", "end_effective": "2028-10-31T01:00:00+01:00", "assignment": "2025-11-14T11:51:58+01:00", "program": 243, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 1, "manager": 104520, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "101201953", "ethics_committee": null, "edudract_number": null, "persons": [ "9390-104520-10" ] }, { "id": 7970, "title": { "de": "Biobanking and Biomolecular resources Research Infrastructure Austria 3.0", "en": "Biobanking and Biomolecular resources Research Infrastructure Austria 3.0" }, "short": "BBMRI.at #3", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2023-12-01T01:00:00+01:00", "begin_effective": "2023-12-01T01:00:00+01:00", "end_planned": "2028-11-30T01:00:00+01:00", "end_effective": "2028-11-30T01:00:00+01:00", "assignment": "2024-01-16T09:22:44+01:00", "program": null, "subprogram": null, "organization": 28392, "category": 10, "type": 10, "partner_function": 4, "manager": 89175, "contact": null, "status": 2, "research": 10, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2164 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "7970-89175-10" ] }, { "id": 7905, "title": { "de": "Biobanking und biomolekulare Ressourcenforschung Infrastruktur Österreich #3", "en": "Biobanking and BioMolecular resources research Infrastructure Austria #3" }, "short": "BBMRI.at#3", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2023-12-01T01:00:00+01:00", "begin_effective": "2023-12-01T01:00:00+01:00", "end_planned": "2028-11-30T01:00:00+01:00", "end_effective": "2028-11-30T01:00:00+01:00", "assignment": "2023-11-24T14:08:12+01:00", "program": null, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 3, "manager": 50496, "contact": null, "status": 2, "research": 10, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2164 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "7905-50496-10" ] }, { "id": 9392, "title": { "de": "Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP-4 BIOMARKERS B-New biomarkers of infection by B threat agents", "en": "Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP-4 BIOMARKERS B-New biomarkers of infection by B threat agents" }, "short": "RESILIENCE-R-2024: SP-4", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2025-11-01T01:00:00+01:00", "begin_effective": "2025-11-01T01:00:00+01:00", "end_planned": "2028-10-31T01:00:00+01:00", "end_effective": "2028-10-31T01:00:00+01:00", "assignment": "2025-11-14T12:14:20+01:00", "program": 243, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 1, "manager": 104520, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "101201953", "ethics_committee": null, "edudract_number": null, "persons": [ "9392-104520-10" ] }, { "id": 9391, "title": { "de": "Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP3-RAPID DIAG-Rapid on field diagnostic tests for B agents (including haemorrhagic fever viruses and orthopox viruses", "en": "Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP3-RAPID DIAG-Rapid on field diagnostic tests for B agents (including haemorrhagic fever viruses and orthopox viruses" }, "short": "RESILIENCE-R-2024: SP-3", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2025-11-01T01:00:00+01:00", "begin_effective": "2025-11-01T01:00:00+01:00", "end_planned": "2028-10-31T01:00:00+01:00", "end_effective": "2028-10-31T01:00:00+01:00", "assignment": "2025-11-14T12:08:13+01:00", "program": 243, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 1, "manager": 104520, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "101201953", "ethics_committee": null, "edudract_number": null, "persons": [ "9391-104520-10" ] }, { "id": 8109, "title": { "de": "New AntiVirals for Infections with Pandemic Potential", "en": "New AntiVirals for Infections with Pandemic Potential" }, "short": "NAVIPP", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2023-11-01T01:00:00+01:00", "begin_effective": "2024-01-01T01:00:00+01:00", "end_planned": "2028-10-31T01:00:00+01:00", "end_effective": "2028-12-31T01:00:00+01:00", "assignment": "2024-03-22T10:42:25+01:00", "program": 211, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 2, "manager": 51663, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8109-51663-10" ] }, { "id": 7935, "title": { "de": "European action for the Diagnosis of Early Non-symptomatic Type 1 diabetes For Intervention", "en": "European action for the Diagnosis of Early Non-symptomatic Type 1 diabetes For Intervention" }, "short": "EDENT1FI", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2023-11-01T01:00:00+01:00", "begin_effective": "2023-11-01T01:00:00+01:00", "end_planned": "2028-10-31T01:00:00+01:00", "end_effective": "2028-10-31T01:00:00+01:00", "assignment": "2023-12-15T12:09:06+01:00", "program": 211, "subprogram": null, "organization": 14080, "category": 10, "type": 10, "partner_function": 2, "manager": 51831, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "GA101132379", "ethics_committee": null, "edudract_number": null, "persons": [ "7935-51831-10", "7935-50452-12", "7935-56667-12", "7935-81132-12", "7935-90274-12", "7935-97867-12", "7935-102575-12", "7935-109149-12" ] }, { "id": 9393, "title": { "de": "Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP-5 WOUNDS B-Treatment of wounds and injuries contaminated by B agents", "en": "Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP-5 WOUNDS B-Treatment of wounds and injuries contaminated by B agents" }, "short": "RESILIENCE-R-2024: SP-5", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2025-11-01T01:00:00+01:00", "begin_effective": "2025-11-01T01:00:00+01:00", "end_planned": "2028-10-31T01:00:00+01:00", "end_effective": "2028-10-31T01:00:00+01:00", "assignment": "2025-11-14T12:19:34+01:00", "program": 243, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 1, "manager": 104520, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "101201953", "ethics_committee": null, "edudract_number": null, "persons": [ "9393-104520-10" ] }, { "id": 9268, "title": { "de": "Cross Regions 4 Health", "en": "Cross Regions 4 Health" }, "short": "CrossReg-4-Health", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2025-10-01T02:00:00+02:00", "begin_effective": "2025-11-01T01:00:00+01:00", "end_planned": "2028-09-30T02:00:00+02:00", "end_effective": "2028-10-30T01:00:00+01:00", "assignment": "2025-10-13T12:38:35+02:00", "program": null, "subprogram": null, "organization": 14051, "category": 10, "type": 10, "partner_function": 1, "manager": 82411, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "9268-82411-10" ] }, { "id": 8535, "title": { "de": "Metabolische Kontrolle von Altern und Krankheit", "en": "Metabolic control of aging and disease" }, "short": "MetAGE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2023-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2028-09-30T02:00:00+02:00", "end_effective": "2029-09-30T02:00:00+02:00", "assignment": "2024-11-29T14:49:59+01:00", "program": 125, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 2, "manager": 94512, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "COE14", "ethics_committee": null, "edudract_number": null, "persons": [ "8535-94512-10", "8535-129380-12" ] }, { "id": 9223, "title": { "de": "Diethylsuccinat als neues Therapeutikum bei IPF", "en": "Diethylsuccinate as a novel therapeutic for IPF" }, "short": "Diethylsuccinat_therapeutic_IPF", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2025-10-01T02:00:00+02:00", "begin_effective": "2025-11-01T01:00:00+01:00", "end_planned": "2028-09-30T02:00:00+02:00", "end_effective": "2029-10-31T01:00:00+01:00", "assignment": "2025-09-24T11:54:15+02:00", "program": 72, "subprogram": null, "organization": 14022, "category": 10, "type": 10, "partner_function": 4, "manager": 85658, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "PAT2165825", "ethics_committee": null, "edudract_number": null, "persons": [ "9223-85658-10", "9223-50132-12", "9223-111587-12", "9223-116746-12", "9223-126994-12" ] } ] }